UBS Group AG - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$67,231
-39.1%
39,782
+0.2%
0.00%
Q2 2023$110,399
-47.0%
39,712
-65.3%
0.00%
Q1 2023$208,168
-88.9%
114,378
-69.0%
0.00%
-100.0%
Q4 2022$1,868,818
+224.4%
368,603
+218.0%
0.00%
Q3 2022$576,000
+209.7%
115,918
+131.5%
0.00%
Q2 2022$186,000
-80.8%
50,073
-71.1%
0.00%
Q1 2022$971,000
-55.0%
173,030
-51.3%
0.00%
-100.0%
Q4 2021$2,159,000
-20.4%
354,987
+27.4%
0.00%0.0%
Q3 2021$2,714,000
+599.5%
278,699
+925.4%
0.00%
Q2 2021$388,000
-70.8%
27,179
-51.5%
0.00%
Q1 2021$1,330,00056,0140.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders